These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 25394467)
1. Synthesis, characterization and in vitro and in vivo investigation of C₃F₈-filled poly(lactic-co-glycolic acid) nanoparticles as an ultrasound contrast agent. Wang CW; Yang SP; Hu H; Du J; Li FH Mol Med Rep; 2015 Mar; 11(3):1885-90. PubMed ID: 25394467 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization, and in vitro evaluation of targeted gold nanoshelled poly(d,l-lactide-co-glycolide) nanoparticles carrying anti p53 antibody as a theranostic agent for ultrasound contrast imaging and photothermal therapy. Xu L; Wan C; Du J; Li H; Liu X; Yang H; Li F J Biomater Sci Polym Ed; 2017 Mar; 28(4):415-430. PubMed ID: 28044473 [TBL] [Abstract][Full Text] [Related]
3. Au-poly(lactic-co-glycolic) acid complex nanoparticles as ultrasound contrast agents: Preparation, characterization and in vitro study. Li XY; Xu L; Li HL; Du J; Liu XS; Li FH Mol Med Rep; 2018 Mar; 17(3):3763-3768. PubMed ID: 29286171 [TBL] [Abstract][Full Text] [Related]
4. Preparation and in vitro evaluation of poly(D,L-lactide-co-glycolide) air-filled nanocapsules as a contrast agent for ultrasound imaging. Néstor MM; Kei NP; Guadalupe NA; Elisa ME; Adriana GQ; David QG Ultrasonics; 2011 Oct; 51(7):839-45. PubMed ID: 21570702 [TBL] [Abstract][Full Text] [Related]
5. Methotrexate-loaded PLGA nanobubbles for ultrasound imaging and Synergistic Targeted therapy of residual tumor during HIFU ablation. Zhang X; Zheng Y; Wang Z; Huang S; Chen Y; Jiang W; Zhang H; Ding M; Li Q; Xiao X; Luo X; Wang Z; Qi H Biomaterials; 2014 Jun; 35(19):5148-61. PubMed ID: 24680663 [TBL] [Abstract][Full Text] [Related]
6. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications. Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353 [TBL] [Abstract][Full Text] [Related]
7. Improved double emulsion technology for fabricating autofluorescent microcapsules as novel ultrasonic/fluorescent dual-modality contrast agents. Gong A; Ma X; Xiang L; Ren W; Shen Z; Wu A Colloids Surf B Biointerfaces; 2014 Apr; 116():561-7. PubMed ID: 24583258 [TBL] [Abstract][Full Text] [Related]
8. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis. Ohashi K; Kabasawa T; Ozeki T; Okada H J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349 [TBL] [Abstract][Full Text] [Related]
9. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications. Chu CH; Wang YC; Huang HY; Wu LC; Yang CS Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469 [TBL] [Abstract][Full Text] [Related]
10. Design of PLGA based nanoparticles for imaging guided applications. Mariano RN; Alberti D; Cutrin JC; Geninatti Crich S; Aime S Mol Pharm; 2014 Nov; 11(11):4100-6. PubMed ID: 25225751 [TBL] [Abstract][Full Text] [Related]
11. Phase-shift, targeted nanoparticles for ultrasound molecular imaging by low intensity focused ultrasound irradiation. Li M; Luo H; Zhang W; He K; Chen Y; Liu J; Chen J; Wang D; Hao L; Ran H; Zheng Y; Wang Z; Li P Int J Nanomedicine; 2018; 13():3907-3920. PubMed ID: 30013344 [TBL] [Abstract][Full Text] [Related]
12. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles. Niu X; Zou W; Liu C; Zhang N; Fu C Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638 [TBL] [Abstract][Full Text] [Related]
13. Ultrasound degradation of novel polymer contrast agents. El-Sherif DM; Lathia JD; Le NT; Wheatley MA J Biomed Mater Res A; 2004 Jan; 68(1):71-8. PubMed ID: 14661251 [TBL] [Abstract][Full Text] [Related]
14. Preparation and Imaging Investigation of Dual-targeted C Du J; Li XY; Hu H; Xu L; Yang SP; Li FH Sci Rep; 2018 Mar; 8(1):3887. PubMed ID: 29497045 [TBL] [Abstract][Full Text] [Related]
15. [Effect of ultrasound contrast agent targeting gelatin on uptake of mouse ascites hepatocellular carcinoma cell lines with high lymphatic metastasis]. He Y; Yang L; Yuan JJ; Zhu HH; Shao LY Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):319-324. PubMed ID: 32375448 [No Abstract] [Full Text] [Related]
16. Hematoporphyrin encapsulated PLGA microbubble for contrast enhanced ultrasound imaging and sonodynamic therapy. Zheng Y; Zhang Y; Ao M; Zhang P; Zhang H; Li P; Qing L; Wang Z; Ran H J Microencapsul; 2012; 29(5):437-44. PubMed ID: 22299595 [TBL] [Abstract][Full Text] [Related]
17. Influence of nanostructure composition on its morphometric characterization by different techniques. Carvalho Silva R; Alexandre Muehlmann L; Rodrigues Da Silva J; de Bentes Azevedo R; Madeira Lucci C Microsc Res Tech; 2014 Sep; 77(9):691-6. PubMed ID: 24919585 [TBL] [Abstract][Full Text] [Related]
18. Comparison of in vitro and in vivo acoustic response of a novel 50:50 PLGA contrast agent. Wheatley MA; Forsberg F; Oum K; Ro R; El-Sherif D Ultrasonics; 2006 Nov; 44(4):360-7. PubMed ID: 16730047 [TBL] [Abstract][Full Text] [Related]
19. Surface modified PLGA nanoparticles for brain targeting of Bacoside-A. Jose S; Sowmya S; Cinu TA; Aleykutty NA; Thomas S; Souto EB Eur J Pharm Sci; 2014 Oct; 63():29-35. PubMed ID: 25010261 [TBL] [Abstract][Full Text] [Related]
20. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment. Feng SS; Zeng W; Teng Lim Y; Zhao L; Yin Win K; Oakley R; Hin Teoh S; Hang Lee RC; Pan S Nanomedicine (Lond); 2007 Jun; 2(3):333-44. PubMed ID: 17716178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]